Du J - Search Results

1

[Efficacy of adjusted BACOD regimen on the treatment of relapsed refractory diffuse large B cell lymphoma].

Gong G, Du J, Dong L, Lei W, Gao X, Fang B, Wei X, Song Y, Li Y. Gong G, et al. Among authors: du j. Zhonghua Xue Ye Xue Za Zhi. 2014 Apr;35(4):295-9. doi: 10.3760/cma.j.issn.0253-2727.2014.04.010. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24759015 Chinese.

2

Treatment with cyclophosphamide, vindesine, cytarabine, dexamethasone and bleomycin in patients with relapsed/refractory diffuse large B-cell lymphoma.

Li M, Li Y, Yin Q, Mi R, Chen L, Du J, Wei X. Li M, et al. Among authors: du j. Leuk Lymphoma. 2014 Jul;55(7):1578-83. doi: 10.3109/10428194.2013.848984. Epub 2014 Feb 11. Leuk Lymphoma. 2014. PMID: 24070424

3

[Primary breast diffuse large B-cell lymphoma-report of 21 cases from China with literatures review].

Sun X, Xu B, Li Y, Du J, Dong L, Gao X, Li G, Wei X, Song Y. Sun X, et al. Among authors: du j. Zhonghua Xue Ye Xue Za Zhi. 2015 Oct;36(10):853-7. doi: 10.3760/cma.j.issn.0253-2727.2015.10.010. Zhonghua Xue Ye Xue Za Zhi. 2015. PMID: 26477765 Free PMC article. Review. Chinese.

4

[Primary renal lymphoma with the initial symptom of nephrotic syndrome: a case report].

Li Y, Wang W, Li Y, Du J, Dong L, Gao X, Li G, Wei X, Song Y. Li Y, et al. Among authors: du j. Zhonghua Xue Ye Xue Za Zhi. 2016 Apr;37(4):277. doi: 10.3760/cma.j.issn.0253-2727.2016.04.004. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 27093986 Free PMC article. Chinese. No abstract available.

5

[Application of all-trans retinoic acid combining chemotherapy and As4S4 in the maintenance treatment of patients with acute promyelocytic leukemia].

Lin QD, Wei XD, Wang P, Liu YY, Zhang LN, Li YF, Gao QL, Zhu XH, Zhang YL, Fang BJ, Yue H, Du JW, Jiang DX, Hu JY, Song YP. Lin QD, et al. Zhonghua Xue Ye Xue Za Zhi. 2007 Jan;28(1):19-21. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 17649720 Clinical Trial. Chinese.

6

[ABVD chemotherapy scheme at day 1 and 8 for treatment of primary Hodgkin's lymphomas].

Li YF, Zhang YL, Fang BJ, DU JW, Lü XD, Zhang LN, Zhu XH, Wei XD, Song YP, Li JC. Li YF, et al. Zhonghua Nei Ke Za Zhi. 2009 Mar;48(3):186-8. Zhonghua Nei Ke Za Zhi. 2009. PMID: 19576082 Clinical Trial. Chinese.

7

[Clinical study of COAD-B regimen in treatment of patients with relapsed/refractory non-Hodgkin lymphoma].

Li MH, Li YF, Yin QS, Mi RH, Chen L, Du JW, Wei XD. Li MH, et al. Zhonghua Xue Ye Xue Za Zhi. 2013 Oct;34(10):857-61. doi: 10.3760/cma.j.issn.0253-2727.2013.10.007. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 24171959 Chinese.

8

Sequential DICE combined with l-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma.

Dong LH, Zhang LJ, Wang WJ, Lei W, Sun X, Du JW, Gao X, Li GP, Li YF. Dong LH, et al. Leuk Lymphoma. 2016 Jul;57(7):1600-6. doi: 10.3109/10428194.2015.1108415. Epub 2016 Jan 4. Leuk Lymphoma. 2016. PMID: 26726970

9

[Expression of TCF3 in Burkitt's Lymphoma and Its Proliferative Effect and Prognostic Significance].

Dong LH, Huang JJ, Liu J, Gao X, DU JW, Li YF. Dong LH, et al. Among authors: du jw. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Oct;30(5):1435-1439. doi: 10.19746/j.cnki.issn.1009-2137.2022.05.020. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022. PMID: 36208246 Chinese.

10

CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR-33a/b to disinhibit PD-L1.

Dong L, Huang J, Gao X, Du J, Wang Y, Zhao L. Dong L, et al. Among authors: du j. Cancer Sci. 2022 Aug;113(8):2888-2903. doi: 10.1111/cas.15402. Epub 2022 Jun 14. Cancer Sci. 2022. PMID: 35579082 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,791 results

Search Page

Filters